They found that average levels of DNA methylation in assigned regulatory regions of MN1, SPARC, ST18, and DHRS3 were significantly lower for inv(16) compared to non-inv(16) AML M4, other AML subtypes, and healthy controls (p < 0.0001). The gene discussed is ST18; the disease is acute myeloid leukemia.